Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT02111460
Eligibility Criteria:
Inclusion Criteria:
* The patients with initial untreated metastatic nasopharyngeal carcinoma
* Histologic diagnosis of nasopharyngeal carcinoma
* T1-4N0-3M1,IVC(according to the 7th AJCC edition)
* Aged between 18 and 65 years
* KPS≥70
* The therapeutic effect evaluation is CR or PR accomplished three course of cisplatin and 5-Fu
* Voluntary to participate and sign informed consent document
Exclusion Criteria:
* The patients suffered from serious neurologic disease
* Clinically significant cardiac, heart function less than or equal to 3 level
* Clinically significant respiratory disease,lung function less than or equal to 3 level
* Blood routine examination: WBC\<3×109/L, Hemoglobin\<90g/L, platelet count\<75×109/L
* Abnormal liver function: total bilirubin or ALT or AST\>2×ULN
* Abnormal renal function:serum creatinine\>1.5×ULN
* Pregnant or lactating women
* The therapeutic effect evaluation is SD or PD accomplished three course of cisplatin and 5-Fu
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02111460
Study Brief:
Protocol Section:
NCT02111460